Skip to main content
. 2017 Feb 10;7:42552. doi: 10.1038/srep42552

Figure 3. Effects of smoking status and rs37973 genotype on ICS efficacy with adjustment for age, sex and baseline percentage of predicted FEV1.

Figure 3

Smokers had significant poor mean (±SD) improvement in covariate-adjusted FEV1, compared with non-smoking patients after 24-week treatment with ICS. ***P < 0.001.